The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. [electronic resource]
Producer: 20150818Description: 1360-6 p. digitalISSN:- 1935-5548
- Antineoplastic Agents -- administration & dosage
- Diabetes Mellitus, Type 2 -- complications
- Double-Blind Method
- Fatty Acids, Omega-3 -- administration & dosage
- Female
- Glycated Hemoglobin -- metabolism
- Humans
- Hypoglycemic Agents -- administration & dosage
- Insulin Glargine
- Insulin, Long-Acting -- administration & dosage
- Metformin -- administration & dosage
- Middle Aged
- Neoplasms -- etiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.